AMA CPT® Assistant - 2022 Issue 5 (May)
New COVID-19 Vaccine Codes: May Update (May Special Update 2022)
May Special Update 2022 page 1 New COVID-19 Vaccine Codes: May Update The Current Procedural Terminology (CPT®) Editorial Panel (the Panel) has approved a new vaccine product code (91311) and its associated vaccine administration codes (0111A, 0112A) for the new Moderna vaccine product to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) in pediatric patients aged 6 months through 5 years. These codes will become effective upon receiving the emergency use authorization (EUA) from the Food and Drug Administration (FDA). In order to assist CPT code users in differentiating and appropriately reporting the available...
Subscribe or sign in to view the full article.
Article Overview
This CPT Assistant special update covers newly approved COVID-19 vaccine coding changes for a pediatric Moderna product, including related administration codes, appendix updates, and contextual guidance from AMA and CDC resources. It is intended for coding professionals, clinicians, and billing staff who need to understand the scope of the CPT changes and the associated supporting materials without relying on the full premium article.
Why This Topic Matters
Keeping current with CPT vaccine updates is important for accurate reporting of pediatric COVID-19 immunization services and for aligning documentation and code selection with the latest CPT and supporting guidance.
Article Sections
-
May Special Update 2022 page 1
Introduces the update and identifies the general coding area addressed in this issue. It provides context for the CPT special edition and the related vaccine guidance resources.
-
Immunization Administration for Vaccines/Toxoids
Discusses the administration portion of the vaccine coding update and the associated reporting framework. It also references related parenthetical guidance and code relationships.
-
Vaccines, Toxoids
Covers the vaccine product portion of the update and its placement within the CPT vaccine section. It notes the related reporting structure and supporting notes.
-
Clinical Example (91311) / Description of Procedure (91311)
Presents a typical scenario and procedure context for the vaccine product code. The section is part of the article’s illustrative material for the new pediatric vaccine coding content.
-
Clinical Example (0111A) / Description of Procedure (0111A)
Presents a typical scenario and procedure context for the first-dose administration code. The section illustrates the broader documentation and reporting environment for the update.
-
Clinical Example (0112A) / Description of Procedure (0112A)
Presents a typical scenario and procedure context for the second-dose administration code. The section continues the article’s illustrative discussion of the updated pediatric vaccine coding structure.
What You Will Learn
- The scope of the CPT update for pediatric COVID-19 vaccine coding
- How the article frames the relationship between vaccine product and administration coding
- What supporting resources and appendix changes are referenced
- How the article uses clinical examples to illustrate the new coding content
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Pediatric practice staff
- Clinicians documenting immunization services
- Coding educators and auditors
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
